Bio-development services

Industry leading cell expression platforms

Celonic offers two standardized cell line development platforms which can be adapted according to the specific needs of our customers.

Innovative industry-leading cell expression platforms

CHOvolution™ is the optimal platform for the high-titer bioproduction of monoclonal antibodies in a fed-batch process, saving time and costs. In case you are dealing with a defucosylated antibody, complex molecule and/or glycosylated protein, our human GEX® platform is the solution.

  • SIMPLIFIED LICENSING MODEL
    (e.g. no royalties from sales)
  • Product derived from CHO and GEX® platforms are in several CLINICAL TRIALS in EU, USA & Asia
  • HIGH SCALE-UP STABILITY
  • Cell lines suspension-adapted to serum-free EMA- and FDA-COMPLIANT MEDIA
  • COMPLIANCE TO cGMP GUIDELINES
  • WELL CHARACTERIZED PARENTAL CELL LINE CULTURED UNDER DOCUMENTED ANIMAL-FREE CONDITIONS

CHOvolution™

  • Powered by Celonic's proprietary SEFEX® technology platform
  • High productivity (capable of delivering up to 8 g/L for mABs)
  • Rapid cell line development: save up to 4 months
  • Real Freedom from royalties and binding terms
Learn more

For more information please contact:
E: chovolution@celonic.com

GEX ®

  • Human cells which can be used to specifically tailor glycosylation
  • Ideal for perfusion cell culture
  • Optimized for complex biopharmaceutical products
  • Stable product quality during entire cell culture process
Learn more

For more information please contact:
E: gex@celonic.com

Need more information?

Contact Celonic

We listen to our clients to understand and to unlock their business potential, leveraging extensive experience and deep industry insights.

Contact us